Suchergebnisse - "Zhong, Dongmei"

PubPharm (32)

1

Cost-Effectiveness Analysis of Camrelizumab Plus Rivoceranib Versus Sorafenib as a First-Line Therapy for Unresectable Hepatocellular Carcinoma in the Chinese Health Care System

enthalten in: Clinical drug investigation | 2024

von Lang, W. | Deng, L. | Huang, B. | +4

2

The impact of telehealth education on self-management in patients with coexisting type 2 diabetes mellitus and hypertension : a 26-week randomized controlled trial

enthalten in: Journal of endocrinological investigation | 2024

von Ye, H. | Lin, L. | Zhong, D. | +4

3

Quality in screening and measuring blood pressure in China's primary health care : a national cross-sectional study using unannounced standardized patients

enthalten in: The Lancet regional health. Western Pacific | 2024

von Zhang, L. | Liang, H. | Luo, H. | +13

4

Mapk7 deletion in chondrocytes causes vertebral defects by reducing MEF2C/PTEN/AKT signaling

enthalten in: Genes & diseases | 2024

von Wu, C. | Liu, H. | Zhong, D. | +10

5

Improving early detection, diagnosis and intervention for children with autism spectrum disorder : A cross-sectional survey in China

enthalten in: Research in developmental disabilities | 2023

von Dai, Y. | Deng, T. | Chen, M. | +7

6

ANTIBODY, REAGENT AND METHOD FOR IDENTIFYING NOVEL CORONAVIRUS MUTANT ANTIGEN

enthalten in: Europäisches Patentamt | 2023

von MENG YUAN | LI WEIZHI | ZHONG DONGMEI | +1

7

ANTIBODY, REAGENT AND METHOD FOR IDENTIFYING NOVEL CORONAVIRUS MUTANT ANTIGEN

enthalten in: Europäisches Patentamt | 2023

von MENG YUAN | LI WEIZHI | ZHONG DONGMEI | +1

8

Epigenetically modified AP-2α by DNA methyltransferase facilitates glioma immune evasion by upregulating PD-L1 expression

enthalten in: Cell death & disease | 2023

von Long, S. | Huang, G. | Ouyang, M. | +9

9

ANTIBODY AGAINST NOVEL CORONAVIRUS AND REAGENT AND KIT FOR TESTING NOVEL CORONAVIRUS

enthalten in: Europäisches Patentamt | 2023

von CUI PENG | HE ZHIQIANG | MENG YUAN | +3

10

ANTIBODY AGAINST DENGUE NS1 PROTEIN AND USE THEREOF

enthalten in: Europäisches Patentamt | 2023

von MENG YUAN | ZHONG DONGMEI | QIN WENXIN